Compile Data Set for Download or QSAR
Report error Found 40 Enz. Inhib. hit(s) with all data for entry = 12669
TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719007BDBM719007(4-(4-[[4-(4-chlorophenyl)-6,6-dimethyl-2,5-dihydro...)
Affinity DataIC50: 0.0100nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719012BDBM719012(4-(4-[[2-(4-chlorophenyl)-5-methoxy-5-methylcycloh...)
Affinity DataIC50: 0.0800nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718987BDBM718987(US12220419, Example 41)
Affinity DataIC50: 0.100nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719005BDBM719005(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 0.100nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718982BDBM718982(4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[...)
Affinity DataIC50: 0.300nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719011BDBM719011(US12220419, Example 76)
Affinity DataIC50: 0.300nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719009BDBM719009(4-(4-[[2-(4-chlorophenyl)cyclohex-1-en-1-yl]methyl...)
Affinity DataIC50: 0.300nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718970BDBM718970(4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[...)
Affinity DataIC50: 0.300nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719001BDBM719001((2S,4R)-1-[(2S)-2-[3-[2-(4-[2-[(4-[[4-(4-[[2-(4-ch...)
Affinity DataIC50: 0.300nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718999BDBM718999((2S,4R)-1-[(2S)-2-(3-[2-[2-(4-[2-[(4-[[4-(4-[[2-(4...)
Affinity DataIC50: 0.400nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719003BDBM719003(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 0.400nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718982BDBM718982(4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[...)
Affinity DataIC50: 0.5nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718993BDBM718993(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 0.5nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718992BDBM718992(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 0.5nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719000BDBM719000( (2S,4R)-1-[(2S)-2-[1-[(4-[[4-(4-[[2-(4-chlorophen...)
Affinity DataIC50: 0.5nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718997BDBM718997((2S,4R)-1-[(2S)-2-[3-(2-[2-[2-(4-[2-[(4-[[4-(4-[[2...)
Affinity DataIC50: 0.600nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719010BDBM719010(4-(4-[[2-(4-chlorophenyl)cyclohept-1-en-1-yl]methy...)
Affinity DataIC50: 0.600nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718994BDBM718994(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 0.600nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719006BDBM719006(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 0.600nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718992BDBM718992(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 0.600nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719004BDBM719004(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 0.600nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718993BDBM718993(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 0.700nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718990BDBM718990(US12220419, Example 44)
Affinity DataIC50: 0.800nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718989BDBM718989(US12220419, Example 43)
Affinity DataIC50: 0.800nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718995BDBM718995(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 0.900nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719008BDBM719008(4-(4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-e...)
Affinity DataIC50: 0.900nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718991BDBM718991(US12220419, Example 45)
Affinity DataIC50: 1nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718998BDBM718998((2S,4R)-1-[(2S)-2-[1-[(4-[[4-(4-[[2-(4-chloropheny...)
Affinity DataIC50: 1.10nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 719002BDBM719002((2S,4R)-1-[(2S)-2-[3-[2-(2-[2-[(4-[[5-(4-[[2-(4-ch...)
Affinity DataIC50: 1.10nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718996BDBM718996(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 1.20nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718974BDBM718974(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 1.20nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718990BDBM718990(US12220419, Example 44)
Affinity DataIC50: 1.30nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718986BDBM718986(2-[7-amino-2H,3H,4H-pyrido[2,3-b][1,4]oxazepin-1-y...)
Affinity DataIC50: 1.5nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718989BDBM718989(US12220419, Example 43)
Affinity DataIC50: 1.5nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718991BDBM718991(US12220419, Example 45)
Affinity DataIC50: 1.60nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718988BDBM718988(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 4.10nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718980BDBM718980(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 27nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718978BDBM718978(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 42.6nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718984BDBM718984(N-(4-[[(2S)-1,4-dioxan-2-ylmethyl]amino]-3-nitrobe...)
Affinity DataIC50: 47nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent

TargetApoptosis regulator Bcl-2(Human)
Newave Pharmaceutical

US Patent
LigandChemical structure of BindingDB Monomer ID 718979BDBM718979(4-(4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-e...)
Affinity DataIC50: 122nMAssay Description:The fluorescence-labeled 23 amino acid peptide BH3 was purchased from CalBiochem (NLWAAQRYGRELRRMSDKFVD). An unbound Fluorescein labeled BH3 peptide ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/15/2025
Entry Details
US Patent